Abiraterone and increased survival in metastatic prostate cancer

Johann S. De Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N. Chi, Robert J. Jones, Oscar B. Goodman, Fred Saad, John N. Staffurth, Paul Mainwaring, Stephen Harland, Thomas W. Flaig, Thomas E. Hutson, Tina Cheng, Helen Patterson, John D. Hainsworth, Charles J. Ryan, Cora N. SternbergSusan L. Ellard, Aude Fléchon, Mansoor Saleh, Mark Scholz, Eleni Efstathiou, Andrea Zivi, Diletta Bianchini, Yohann Loriot, Nicole Chieffo, Thian Kheoh, Christopher M. Haqq, Howard I. Scher

Research output: Contribution to journal › Article › peer-review

3706 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Abiraterone and increased survival in metastatic prostate cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science